US3272204A
(en)
*
|
1965-09-22 |
1966-09-13 |
Ethicon Inc |
Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
|
US4172128A
(en)
|
1975-03-26 |
1979-10-23 |
Erhard Thiele |
Process of degrading and regenerating bone and tooth material and products
|
GB1537448A
(en)
*
|
1976-08-20 |
1978-12-29 |
Sumitomo Electric Industries |
Vascular prostheses and process for production thereof
|
US4842575A
(en)
*
|
1984-01-30 |
1989-06-27 |
Meadox Medicals, Inc. |
Method for forming impregnated synthetic vascular grafts
|
US5197977A
(en)
*
|
1984-01-30 |
1993-03-30 |
Meadox Medicals, Inc. |
Drug delivery collagen-impregnated synthetic vascular graft
|
US4563350A
(en)
*
|
1984-10-24 |
1986-01-07 |
Collagen Corporation |
Inductive collagen based bone repair preparations
|
GB8430265D0
(en)
*
|
1984-11-30 |
1985-01-09 |
Vascutek Ltd |
Vascular graft
|
US5859208A
(en)
*
|
1988-07-06 |
1999-01-12 |
Fiddes; John C. |
Human basic fibroblast growth factor analog
|
US5658894A
(en)
*
|
1989-04-23 |
1997-08-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for inhibiting restenosis
|
US6018026A
(en)
|
1988-01-22 |
2000-01-25 |
Zymogenetics, Inc. |
Biologically active dimerized and multimerized polypeptide fusions
|
FI890312A
(fi)
*
|
1988-01-25 |
1989-07-26 |
Oncogen |
Amfiregulin: ett nytt bifunktionellt tillvaext modulerande glykoprotein.
|
US6919308B2
(en)
|
1988-04-08 |
2005-07-19 |
Stryker Corporation |
Osteogenic devices
|
US5202311A
(en)
*
|
1988-08-19 |
1993-04-13 |
Children's Medical Center Corporation |
Stabilized fgf composition
|
US5108436A
(en)
*
|
1988-09-29 |
1992-04-28 |
Collagen Corporation |
Implant fixation
|
US5510418A
(en)
*
|
1988-11-21 |
1996-04-23 |
Collagen Corporation |
Glycosaminoglycan-synthetic polymer conjugates
|
US5576288A
(en)
|
1989-04-27 |
1996-11-19 |
The Salk Institute For Biological Studies |
Fibroblast growth factor conjugates
|
US5759515A
(en)
*
|
1989-08-09 |
1998-06-02 |
Rhomed Incorporated |
Polyvalent peptide pharmaceutical applications
|
US5380536A
(en)
*
|
1990-10-15 |
1995-01-10 |
The Board Of Regents, The University Of Texas System |
Biocompatible microcapsules
|
US5270197A
(en)
*
|
1990-12-20 |
1993-12-14 |
The Children's Medical Center Corporation |
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor
|
GB9101645D0
(en)
*
|
1991-01-25 |
1991-03-06 |
British Bio Technology |
Compounds
|
US5728802A
(en)
*
|
1992-05-06 |
1998-03-17 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
|
US5643873A
(en)
*
|
1992-05-06 |
1997-07-01 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
|
US5648458A
(en)
*
|
1992-05-06 |
1997-07-15 |
Affymax Technologies N.V. |
Peptides and compounds that bind to ELAM-1
|
US5326695A
(en)
*
|
1992-05-15 |
1994-07-05 |
Ludwig Institute For Cancer Research |
Platelet derived growth factor agonists
|
ES2257734T3
(es)
*
|
1992-05-18 |
2006-08-01 |
Genentech, Inc. |
Activacion de los receptores de oligomerizacion por medio de los ligandos de receptores fusionados.
|
US5684136A
(en)
|
1992-05-18 |
1997-11-04 |
Genentech, Inc. |
Chimeric hepatocyte growth factor (HGF) ligand variants
|
US5643756A
(en)
*
|
1992-08-28 |
1997-07-01 |
The Public Health Research Institute Of The City Of New York, Inc. |
Fusion glycoproteins
|
US5679673A
(en)
|
1992-09-24 |
1997-10-21 |
The United States Of America, Represented By The Department Of Health And Human Services |
Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
|
US6057133A
(en)
*
|
1992-11-24 |
2000-05-02 |
G. D. Searle |
Multivariant human IL-3 fusion proteins and their recombinant production
|
US5674977A
(en)
|
1993-02-05 |
1997-10-07 |
The Ontario Cancer Institute |
Branched synthetic peptide conjugate
|
US6174530B1
(en)
*
|
1993-05-05 |
2001-01-16 |
Gryphon Sciences |
Homogeneous polyoxime compositions and their preparation by parallel assembly
|
US6001364A
(en)
*
|
1993-05-05 |
1999-12-14 |
Gryphon Sciences |
Hetero-polyoxime compounds and their preparation by parallel assembly
|
US5563046A
(en)
|
1993-08-02 |
1996-10-08 |
Celtrix Pharmaceuticals, Inc. |
Fusion polypeptides and proteins
|
US6284503B1
(en)
*
|
1993-08-20 |
2001-09-04 |
University Of Utah Research Foundation |
Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
|
US5952304A
(en)
*
|
1993-10-22 |
1999-09-14 |
Trigen Limited |
Platelet-derived growth factor analogues
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
US5773569A
(en)
*
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
US5880096A
(en)
*
|
1994-02-02 |
1999-03-09 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
US5786331A
(en)
*
|
1994-02-02 |
1998-07-28 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
US5608035A
(en)
*
|
1994-02-02 |
1997-03-04 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
US5861476A
(en)
*
|
1994-02-02 |
1999-01-19 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-1 receptor
|
US5635599A
(en)
*
|
1994-04-08 |
1997-06-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Fusion proteins comprising circularly permuted ligands
|
US5635597A
(en)
*
|
1994-05-27 |
1997-06-03 |
Affymax Technologies, N.V. |
Peptides that bind IL-2 receptors
|
US5589359A
(en)
*
|
1994-08-05 |
1996-12-31 |
Chiron Corporation |
Chimeric proteins
|
US5665114A
(en)
*
|
1994-08-12 |
1997-09-09 |
Meadox Medicals, Inc. |
Tubular expanded polytetrafluoroethylene implantable prostheses
|
US5650234A
(en)
*
|
1994-09-09 |
1997-07-22 |
Surface Engineering Technologies, Division Of Innerdyne, Inc. |
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
|
US5509899A
(en)
*
|
1994-09-22 |
1996-04-23 |
Boston Scientific Corp. |
Medical device with lubricious coating
|
US5932462A
(en)
*
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
US5919570A
(en)
*
|
1995-02-01 |
1999-07-06 |
Schneider Inc. |
Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices
|
US6231600B1
(en)
*
|
1995-02-22 |
2001-05-15 |
Scimed Life Systems, Inc. |
Stents with hybrid coating for medical devices
|
US6099562A
(en)
*
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
US5668110A
(en)
*
|
1995-06-07 |
1997-09-16 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US5869451A
(en)
*
|
1995-06-07 |
1999-02-09 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
US5654276A
(en)
*
|
1995-06-07 |
1997-08-05 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US6251864B1
(en)
*
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
US6491965B1
(en)
*
|
1995-11-30 |
2002-12-10 |
Hamilton Civic Hospitals Research Development, Inc. |
Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
|
US6048964A
(en)
|
1995-12-12 |
2000-04-11 |
Stryker Corporation |
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
|
US6458889B1
(en)
*
|
1995-12-18 |
2002-10-01 |
Cohesion Technologies, Inc. |
Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
|
DK1704878T3
(da)
*
|
1995-12-18 |
2013-07-01 |
Angiodevice Internat Gmbh |
Tværbundne polymerpræparater og fremgangsmåder til deres anvendelse
|
GB9608882D0
(en)
*
|
1996-04-30 |
1996-07-03 |
Luthra Ajay K |
Non-thrombogenic and anti-thrombogenic polymers
|
US5811151A
(en)
*
|
1996-05-31 |
1998-09-22 |
Medtronic, Inc. |
Method of modifying the surface of a medical device
|
US5916585A
(en)
*
|
1996-06-03 |
1999-06-29 |
Gore Enterprise Holdings, Inc. |
Materials and method for the immobilization of bioactive species onto biodegradable polymers
|
US5965532A
(en)
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
US6060534A
(en)
*
|
1996-07-11 |
2000-05-09 |
Scimed Life Systems, Inc. |
Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
|
US6306165B1
(en)
*
|
1996-09-13 |
2001-10-23 |
Meadox Medicals |
ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin
|
BR9712348B1
(pt)
|
1996-10-16 |
2013-06-18 |
|
vetor de expressão, célula de bactéria ou levedura transformada ou transfectada, processo para produzir um polipeptídeo homólogo de fgf, composição farmacêutica, e, processos para estimular ex vivo células progenitoras de miócitos ou miócitos
|
US5994104A
(en)
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
US6214795B1
(en)
*
|
1996-11-12 |
2001-04-10 |
Praecis Pharmaceuticals, Inc. |
Peptide compounds useful for modulating FGF receptor activity
|
WO1998034655A1
(en)
*
|
1997-02-07 |
1998-08-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
ES2235336T3
(es)
|
1997-06-13 |
2005-07-01 |
Gryphon Therapeutics, Inc. |
Ligacion quimica nativa en fase solida de peptidos desprotegidos o protegidos en la cisteina n-terminal en solucion acuosa.
|
US6168784B1
(en)
*
|
1997-09-03 |
2001-01-02 |
Gryphon Sciences |
N-terminal modifications of RANTES and methods of use
|
US5945457A
(en)
*
|
1997-10-01 |
1999-08-31 |
A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science |
Process for preparing biologically compatible polymers and their use in medical devices
|
US5955588A
(en)
*
|
1997-12-22 |
1999-09-21 |
Innerdyne, Inc. |
Non-thrombogenic coating composition and methods for using same
|
US6410044B1
(en)
*
|
1998-03-19 |
2002-06-25 |
Surmodics, Inc. |
Crosslinkable macromers
|
US6121236A
(en)
*
|
1998-03-24 |
2000-09-19 |
The Children's Medical Center Corporation |
Multivalent ligands which modulate angiogenesis
|
DE19814057B4
(de)
*
|
1998-03-30 |
2009-01-02 |
Carl Zeiss Meditec Ag |
Anordnung zur optischen Kohärenztomographie und Kohärenztopographie
|
US6258371B1
(en)
*
|
1998-04-03 |
2001-07-10 |
Medtronic Inc |
Method for making biocompatible medical article
|
JP2002524108A
(ja)
*
|
1998-07-28 |
2002-08-06 |
インナーダイン, インコーポレイテッド |
吸収性近接照射療法および化学療法送達デバイスならびに方法
|
US6514534B1
(en)
*
|
1998-08-14 |
2003-02-04 |
Incept Llc |
Methods for forming regional tissue adherent barriers and drug delivery systems
|
US6818018B1
(en)
*
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
DE69932249T2
(de)
*
|
1998-08-31 |
2007-07-26 |
Amylin Pharmaceuticals, Inc. (n.d.Ges.d. Staates Delaware), San Diego |
Chemische anknüpfung unter einbeziehung von einer lipid-matrix und herstellung von membranpolypeptiden
|
US6596699B2
(en)
*
|
1998-09-22 |
2003-07-22 |
Biosurface Engineering Technologies, Inc. |
Nucleic acid coating compositions and methods
|
US6921811B2
(en)
*
|
1998-09-22 |
2005-07-26 |
Biosurface Engineering Technologies, Inc. |
Bioactive coating composition and methods
|
US6342591B1
(en)
*
|
1998-09-22 |
2002-01-29 |
Biosurface Engineering Technologies, Inc. |
Amphipathic coating for modulating cellular adhesion composition and methods
|
US6548634B1
(en)
*
|
1998-09-30 |
2003-04-15 |
Chiron Corporation |
Synthetic peptides having FGF receptor affinity
|
DE69924749T2
(de)
*
|
1998-11-20 |
2006-04-27 |
The University Of Connecticut, Farmington |
Generisch integrierte implantierbare Potentiostatfernmeßanordnung für elektrochemische Fühler
|
US6368347B1
(en)
*
|
1999-04-23 |
2002-04-09 |
Sulzer Vascutek Ltd. |
Expanded polytetrafluoroethylene vascular graft with coating
|
US6309660B1
(en)
*
|
1999-07-28 |
2001-10-30 |
Edwards Lifesciences Corp. |
Universal biocompatible coating platform for medical devices
|
US6458162B1
(en)
*
|
1999-08-13 |
2002-10-01 |
Vita Special Purpose Corporation |
Composite shaped bodies and methods for their production and use
|
AU2432501A
(en)
*
|
1999-12-28 |
2001-07-09 |
Osteotech, Inc. |
Calcium phosphate bone graft material and osteoimplant fabricated therefrom
|
US6585765B1
(en)
*
|
2000-06-29 |
2003-07-01 |
Advanced Cardiovascular Systems, Inc. |
Implantable device having substances impregnated therein and a method of impregnating the same
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
US6984393B2
(en)
*
|
2001-05-07 |
2006-01-10 |
Queen's University At Kingston |
Biodegradable elastomer and method of preparing same
|
US7297343B2
(en)
*
|
2001-07-31 |
2007-11-20 |
Biosurface Engineering Technologies, Inc. |
Bioactive medical films
|
US7166574B2
(en)
*
|
2002-08-20 |
2007-01-23 |
Biosurface Engineering Technologies, Inc. |
Synthetic heparin-binding growth factor analogs
|
US8227411B2
(en)
*
|
2002-08-20 |
2012-07-24 |
BioSurface Engineering Technologies, Incle |
FGF growth factor analogs
|
US7598224B2
(en)
*
|
2002-08-20 |
2009-10-06 |
Biosurface Engineering Technologies, Inc. |
Dual chain synthetic heparin-binding growth factor analogs
|
US7135027B2
(en)
*
|
2002-10-04 |
2006-11-14 |
Baxter International, Inc. |
Devices and methods for mixing and extruding medically useful compositions
|
US7468210B1
(en)
*
|
2002-12-10 |
2008-12-23 |
Biosurface Engineering Technologies, Inc. |
Cross-linked heparin coatings and methods
|
WO2005065079A2
(en)
*
|
2003-11-10 |
2005-07-21 |
Angiotech International Ag |
Medical implants and fibrosis-inducing agents
|
US7234787B2
(en)
*
|
2004-01-08 |
2007-06-26 |
Eastman Kodak Company |
Liquid level detection method and apparatus
|
US7414028B1
(en)
*
|
2004-02-04 |
2008-08-19 |
Biosurface Engineering Technologies, Inc. |
Growth factor analogs
|
US7528105B1
(en)
*
|
2004-02-10 |
2009-05-05 |
Biosurface Engineering Technologies |
Heterodimeric chain synthetic heparin-binding growth factor analogs
|
US20080227696A1
(en)
|
2005-02-22 |
2008-09-18 |
Biosurface Engineering Technologies, Inc. |
Single branch heparin-binding growth factor analogs
|
US7671012B2
(en)
*
|
2004-02-10 |
2010-03-02 |
Biosurface Engineering Technologies, Inc. |
Formulations and methods for delivery of growth factor analogs
|
US20060024347A1
(en)
*
|
2004-02-10 |
2006-02-02 |
Biosurface Engineering Technologies, Inc. |
Bioactive peptide coatings
|
CA2555583A1
(en)
*
|
2004-02-20 |
2005-09-09 |
Biosurface Engineering Technologies, Inc. |
Positive modulator of bone morphogenic protein-2
|
DE102004045176B4
(de)
*
|
2004-09-17 |
2011-07-21 |
Adidas International Marketing B.V. |
Blase
|
US20090111743A1
(en)
*
|
2005-02-25 |
2009-04-30 |
Biosurface Engineering Technologies, Inc. |
Cysteine-branched heparin-binding growth factor analogs
|
EP2046350A4
(en)
*
|
2006-06-22 |
2011-09-14 |
Biosurface Eng Tech Inc |
COMPOSITIONS AND METHOD FOR THE RELEASE OF A BMP-2 AMPLIFIER / COACTIVATOR FOR REINFORCED OSTEOGENESIS
|